KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Repligen (RGEN) Shares Issued (2016 - 2025)

Repligen (RGEN) has disclosed Shares Issued for 16 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 46.37% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.2 million through Dec 2025, down 26.04% year-over-year, with the annual reading at $3.2 million for FY2025, 26.04% down from the prior year.
  • Shares Issued for Q4 2025 was $1.0 million at Repligen, up from $678000.0 in the prior quarter.
  • The five-year high for Shares Issued was $2.3 million in Q3 2022, with the low at $29000.0 in Q1 2023.
  • Average Shares Issued over 5 years is $849052.6, with a median of $720000.0 recorded in 2023.
  • The sharpest move saw Shares Issued plummeted 90.77% in 2021, then skyrocketed 3158.62% in 2024.
  • Over 5 years, Shares Issued stood at $1.9 million in 2021, then tumbled by 51.11% to $923000.0 in 2022, then dropped by 21.99% to $720000.0 in 2023, then skyrocketed by 167.78% to $1.9 million in 2024, then plummeted by 46.37% to $1.0 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.0 million, $678000.0, and $1.5 million for Q4 2025, Q3 2025, and Q1 2025 respectively.